Scarica l'app Stockscreener
12.04
8.96%
0.99
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$11.05
Aprire:
$11.07
Volume 24 ore:
1.04M
Relative Volume:
0.90
Capitalizzazione di mercato:
$937.82M
Reddito:
$1.53B
Utile/perdita netta:
$40.23M
Rapporto P/E:
24.08
EPS:
0.5
Flusso di cassa netto:
$60.93M
1 W Prestazione:
+2.47%
1M Prestazione:
-24.18%
6M Prestazione:
-5.12%
1 anno Prestazione:
-47.65%
Intervallo 1D:
$11.05
$12.31
Intervallo di 1 settimana:
$10.91
$12.31
Portata 52W:
$10.87
$27.13
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Nome
Integra Lifesciences Holdings Corp
Settore
Industria
Telefono
(609) 275-0500
Indirizzo
1100 CAMPUS ROAD, PRINCETON, NJ
Confronta IART con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
12.04 | 860.71M | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-31 | Aggiornamento | Argus | Hold → Buy |
| 2024-12-02 | Iniziato | Morgan Stanley | Underweight |
| 2024-10-07 | Aggiornamento | BTIG Research | Sell → Neutral |
| 2024-07-30 | Downgrade | BTIG Research | Neutral → Sell |
| 2024-07-30 | Downgrade | Citigroup | Neutral → Sell |
| 2024-05-07 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-05-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-12-05 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | Iniziato | CL King | Buy |
| 2023-08-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-06-08 | Downgrade | Argus | Buy → Hold |
| 2023-05-24 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Downgrade | Citigroup | Neutral → Sell |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-07-25 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2021-12-17 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2021-09-15 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-10-08 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-05-27 | Iniziato | Citigroup | Neutral |
| 2020-04-03 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | Iniziato | SunTrust | Buy |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-08-07 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2018-07-02 | Downgrade | Citigroup | Buy → Neutral |
| 2018-01-05 | Ripresa | Cantor Fitzgerald | Neutral |
| 2018-01-02 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | Downgrade | JP Morgan | Overweight → Neutral |
| 2017-06-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-05-02 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | Iniziato | UBS | Buy |
Mostra tutto
Integra Lifesciences Holdings Corp Borsa (IART) Ultime notizie
Align Technology, Tandem Diabetes, Integra LifeSciences, Lantheus, and Inspire Medical Systems Shares Skyrocket, What You Need To Know - Yahoo Finance
How robust is Integra LifeSciences Holdings Corporation (IL3) stock financial positionAnalyst Downgrade & Safe Capital Preservation Plans - newser.com
Why Integra LifeSciences Holdings Corporation stock is recommended by analystsEarnings Summary Report & Weekly Stock Performance Updates - newser.com
Is Integra LifeSciences Holdings Corporation (IL3) stock vulnerable to rate hikes - newser.com
How Integra LifeSciences Holdings Corporation (IL3) stock responds to bond marketJuly 2025 EndofMonth & Fast Entry High Yield Stock Tips - newser.com
How institutional ownership impacts Integra LifeSciences Holdings Corporation stock2025 Year in Review & Risk Controlled Swing Trade Alerts - newser.com
Is Integra LifeSciences Holdings Corporation stock cheap at current valuation2025 Bull vs Bear & Safe Swing Trade Setups - newser.com
Does Integra LifeSciences Holdings Corporation show high probability of reboundJuly 2025 Update & Fast Gain Stock Trading Tips - newser.com
How buyback programs support Integra LifeSciences Holdings Corporation (IL3) stockTrade Analysis Report & Risk Managed Investment Signals - newser.com
FDA Grants 510(k) Clearance to Ultrasonic Surgical Aspirator System for Cardiac Surgeries - Diagnostic and Interventional Cardiology
Surgical Equipment & ConsumablesSpecialty Stocks Q3 Recap: Benchmarking Integra LifeSciences (NASDAQ:IART) - Yahoo Finance
Is Integra LifeSciences Holdings Corporation stock vulnerable to regulatory risksJuly 2025 Summary & Verified Momentum Watchlists - newser.com
Is Integra LifeSciences Holdings Corporation stock a buy for dividend growthWeekly Trade Summary & Real-Time Buy Signal Notifications - newser.com
Integra LifeSciences Holdings Corporation stock volume spike explainedStop Loss & Expert Verified Movement Alerts - newser.com
Integra LifeSciences (IART) Stock Trades Up, Here Is Why - Finviz
Integra LifeSciences (IART) Gains FDA Clearance for Cardiac Surg - GuruFocus
Integra LifeSciences stock jumps after FDA clearance for cardiac surgery device By Investing.com - Investing.com South Africa
Integra LifeSciences stock jumps after FDA clearance for cardiac surgery device - Investing.com
Integra LifeSciences Receives FDA Clearance for CUSA Clarity Ultrasonic Surgical Aspirator in Cardiac Surgery Applications - Quiver Quantitative
Integra (NASDAQ: IART) gets FDA 510(k) for CUSA Clarity in cardiac surgery valve repair - Stock Titan
Regenerative Medicine Market Research Report 2025 Featuring Stryker, Athersys, Integra Lifesciences, Isto Biologics, Organogenesis, CryoLife, Medtronic, U.S. Stem Cell, Zimmer Biomet, and 3M - Yahoo Finance
Is Integra LifeSciences Holdings Corporation stock poised for growth2025 Growth vs Value & Risk Managed Investment Entry Signals - newser.com
Insider Buying: Jeffrey Graves Acquires Shares of Integra Lifesc - GuruFocus
[Form 4] INTEGRA LIFESCIENCES HOLDINGS CORP Insider Trading Activity - Stock Titan
Why Integra LifeSciences Holdings Corporation stock attracts global investorsJuly 2025 Weekly Recap & Community Consensus Trade Alerts - Fundação Cultural do Pará
Integra LifeSciences Holdings Corporation stock trend forecastWeekly Trade Recap & Low Risk Profit Maximizing Plans - newser.com
5 Must-Read Analyst Questions From Integra LifeSciences’s Q3 Earnings Call - Yahoo Finance
Will Integra LifeSciences Holdings Corporation (IL3) stock profit from AI boomWeekly Risk Summary & Daily Oversold Stock Bounce Ideas - newser.com
Published on: 2025-11-05 09:55:55 - newser.com
How to use Fibonacci retracement on Integra LifeSciences Holdings CorporationIPO Watch & Weekly Top Stock Performers List - newser.com
Why Integra LifeSciences (IART) Shares Are Trading Lower Today - Yahoo Finance
Integra Lifesciences (IART) Sees Revised Analyst Ratings Today | - GuruFocus
Is Integra LifeSciences Holdings Corporation (IL3) stock a top pick for value investors2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Published on: 2025-11-03 05:22:14 - newser.com
Integra Lifesciences Holdings Corp Azioni (IART) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):